公共咨询

医疗器械登记 到 ANVISA

按号码、产品、持有公司或CNPJ搜索,数据是ANVISA在公开数据中发布的,每天都会到达这里。

记录的 ROCHE DIAGNÓSTICA BRASIL LTDA取消

72 记录

产品持有公司班级有效性
COBAS HCV 480010287411152ROCHE DIAGNÓSTICA BRASIL LTDAIV01/08/2036
COBAS MPX10287411182ROCHE DIAGNÓSTICA BRASIL LTDAIV19/12/2026
COBAS® AmpliPrep/COBAS® TaqMan® HCV Qualitative Test, v2.010287410994ROCHE DIAGNÓSTICA BRASIL LTDAIV13/02/2028
Cobas Buffer Negative Control Kit10287411091ROCHE DIAGNÓSTICA BRASIL LTDAIV27/07/2035
Cobas CMV10287411104ROCHE DIAGNÓSTICA BRASIL LTDAIV10/08/2035
Cobas CMV Control Kit10287411102ROCHE DIAGNÓSTICA BRASIL LTDAIV10/08/2035
Cobas HBV10287411154ROCHE DIAGNÓSTICA BRASIL LTDAIV01/08/2036
Cobas HBV 5800 6800 880010287411129ROCHE DIAGNÓSTICA BRASIL LTDAIV23/05/2036
Cobas HBV/HCV/HIV-1 Control Kit10287411180ROCHE DIAGNÓSTICA BRASIL LTDAIV19/12/2036
Cobas HBV/HCV/HIV-1 Control Kit 480010287411161ROCHE DIAGNÓSTICA BRASIL LTDAIV05/09/2036
Cobas HCV10287411181ROCHE DIAGNÓSTICA BRASIL LTDAIV19/12/2036
Cobas HIV-110287411134ROCHE DIAGNÓSTICA BRASIL LTDAIV27/06/2036
Cobas HIV-1 480010287411153ROCHE DIAGNÓSTICA BRASIL LTDAIV01/08/2036
Cobas MPX Control Kit10287411124ROCHE DIAGNÓSTICA BRASIL LTDAIV28/03/2036
Cobas NHP negative Control Kit10287411092ROCHE DIAGNÓSTICA BRASIL LTDAIV27/07/2035
Cobas TaqScreen MPX Test, v2.010287411062ROCHE DIAGNÓSTICA BRASIL LTDAIV29/09/2034
Cobas® TaqScreen MPX Control Kit, v2.010287411058ROCHE DIAGNÓSTICA BRASIL LTDAIV22/09/2034
ELECSYS HBSAG II10287410744ROCHE DIAGNÓSTICA BRASIL LTDAIV21/07/2033
ELECSYS HBSAG TESTE CONFIRMATORIO10287410358ROCHE DIAGNÓSTICA BRASIL LTDAIV24/09/2034
ELECSYS PRECICONTROL ANTI-HBS10287410371ROCHE DIAGNÓSTICA BRASIL LTDAIV29/10/2034
ELECSYS PRECICONTROL HBsAg II10287410748ROCHE DIAGNÓSTICA BRASIL LTDAIV21/07/2033
Elecsys Anti-HBe10287411321ROCHE DIAGNÓSTICA BRASIL LTDAIV26/03/2028
Elecsys Anti-HBs II10287411316ROCHE DIAGNÓSTICA BRASIL LTDAIV26/03/2028
Elecsys Anti-HCV II 0883698119010287411665ROCHE DIAGNÓSTICA BRASIL LTDAIV31/07/2033
Elecsys Anti-HCV II 0883703119010287411666ROCHE DIAGNÓSTICA BRASIL LTDAIV31/07/2033

来源: ANVISA 开放数据,健康产品档案. 基础带来注册的有效性,而不是记录情况:注册可能在期限之前被取消,而不会在这里出现。 咨询门户 ANVISA.

接下来的步骤

您的产品需要在巴西注册

HSC在 ANVISA 中进行医疗器械登记,从风险类框架到过程跟踪。

联系专家